Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Tissue Reactions|February 6, 2004
Microvascular assessment in Behçet disease: videocapillaroscopic studyA L Pasqui, M Pastorelli, L Puccetti, et al.
European Neurology|January 1, 1983
Mitral valve prolapse as a risk factor for TIA. A study with echocardiography and dynamic ECGC Fieschi, A Francia, L Allori, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|February 9, 2011
[Bladder malformations in a model of myelomeningocele. Preliminary report]J L Encinas, M Germani, L Burgos, et al.
Obesity Surgery|May 2, 2008
BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefitsF De Peppo, G Di Giorgio, M Germani, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|June 29, 2010
[Prenatal techniques to prevent central nervous system malformations in the surgically induced model of myelomeningocele]J L Encinas, M Germani, A Luis, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2022
Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studiesDaniele Rossini, Marco M Germani, Sara Lonardi, et al.
ESMO Open|April 13, 2024
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide datasetM M Germani, G Vetere, F Santamaria, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 studyRoberto Moretto, Mirella Giordano, Anello M Poma, et al.
ESMO Open|April 17, 2024
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experienceR Moretto, M M Germani, B Borelli, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 2022
Early modulation of Angiopoietin-2 plasma levels predicts benefit from regorafenib in patients with metastatic colorectal cancerCarlotta Antoniotti, Federica Marmorino, Alessandra Boccaccino, et al.
Pageof 4